Medpage Today on MSN21h
Semaglutide Tied to Small Risk of Potentially Blinding Eye Condition
The use of semaglutide (Ozempic) was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in ...
Medscape3d
Obinutuzumab a Success in Phase 3 Trial for Lupus Nephritis
Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...
FiercePharma13h
Genentech, Novartis join forces to raise awareness of food allergies’ impact on families
Genentech and Novartis have teamed up with Food Allergy Research & Education (FARE) to enhance the safety of children with ...
Food Allergy Research & Education1d
FARE Teams Up with Genentech and Novartis to Launch Food Allergy Educational Initiative
To learn more about food allergies or access FARE resources, please visit foodallergy.org.
FierceBiotech7d
Genentech archives diversity reports amid site update, examines ‘potential implications of executive orders’
Roche’s U.S. biotech subsidiary Genentech has wiped its website of past diversity reports as the company’s diversity and ...
FierceBiotech11h
German research institute teams up with Barbados to improve cardiometabolic treatments for Black individuals
BioMed X Institute is teaming up with the Barbados government in an effort to accelerate cardiometabolic treatments for ...
MedPage Today4h
Researchers Describe Rare Syndrome After COVID Vaccine
Immune cell populations of people with post-vaccination syndrome had lower levels of effector CD4 T cells and higher levels ...
Pharmaceutical Technology13d
Genentech eyes lupus market for Gazyva with positive Phase III data readout
Genentech has shared positive data from the Phase III REGENCY trial with regulators in the US and EU. Roche’s subsidiary ...
FDA Approves Genentech’s Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy (SMA)
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug ...
Pharma Companies Turn to AI to Speed Up Drug Development, But Hit Hurdles
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
Business Wire16d
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo ...
Hosted on MSN22h
State's community colleges mark Career Education Month
It's an economic engine not only for California but also for the United States, and remains the nation's largest workforce training provider: the Golden State's community colleges. And this month the ...